However, we did not detect any statistical difference in PIK3CAAmp/TP53Mutated HNSCC patients who expressed high vs. low level of CSF1, VEGF-A, VEGF-B singularly or CSF1/VEGF-A or CSF1/VEGF-B combinatorially (Fig. S7). This evidence concerns the gene VEGFB and head and neck squamous cell carcinoma.